Overview

A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

Summary

This study evaluates the safety and efficacy of endoscopic cryoballoon ablation treatment (ECAT) combined with a PD-1 inhibitor (sintilimab) as maintenance therapy in patients with advanced gastric cancer, and further explores the underlying immunoregulatory mechanisms.

Phase:

PHASE2

Details

Lead Sponsor:

Zhongguang Luo, MD

Treatments:

Immune Checkpoint Inhibitors